Benefits (Tables)

12 Months Ended

Jun. 26, 2021

Retirement Benefits [Abstract]

Schedule of Net Funded Status [Table Text Block]

U.S. Employees Postretirement Medical Expense & Funded Status Reconciliation

The Company provides postretirement medical expenses to certain former employees of Dallas Semiconductor and to certain Maxim Integrated executives. The Company adopted the postretirement medical plan as a result of the Company's acquisition of Dallas Semiconductor in 2001. A reconciliation of the funded status of these postretirement benefits, is as follows:

	June 26, 2021		Estimated Fiscal Year 2022 Expense		June 27, 2020		Fiscal Year 2021 Expense
	(in thousands, except percentages)
Accumulated postretirement benefit obligation:
Retirees and beneficiaries	$	(19,483)			$	(19,115)
Active participants	—				(1,413)
Funded status	$	(19,483)			$	(20,528)
Actuarial gain (loss)	$	1,152			$	705
Prior service cost	—				—
Amounts recognized in accumulated other comprehensive income:
Net actuarial loss	$	725			$	1,877
Prior service cost	—				249
Total	$	725			$	2,126
Net periodic postretirement benefit cost:
Interest cost			$	527			$	524
Amortization:
Prior service cost			—				249
Total net periodic postretirement benefit cost			$	527			$	773
Employer contributions			$	420			$	740
Economic assumptions:
Discount rate	2.9%				2.6%
Medical trend	6.75%-5.00%				7.00%-5.00%

Schedule of Expected Benefit Payments [Table Text Block]

The following benefit payments are expected to be paid:

	Non-Pension Benefits
Fiscal Year	(in thousands)
2022	$	851
2023	819
2024	870
2025	919
2026	903
Thereafter	15,121
Total	$	19,483